Fritextsökning
Innehållstyper
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Tio minuters trädgårdsarbete räcker
Så lite som tio minuters motion per vecka ser ut att minska risken för hjärtdöd, enligt en kinesisk observationsstudie.
-
GSK:s ebolavaccin får snabbspår i FDA
Nu inleder bolaget patientstudier i friska frivilliga.
-
Tio miljoner till AMRA
Analysföretaget får ytterligare finansiering från Industrifonden.
-
Han lämnade Harvard för KI
Målet är en metod att få skadade hjärtan att laga sig själva. För Harvardprofessorn Kenneth Chien stod det klart att nästa steg i hans forskning var att byta mo...
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Uppsala i toppen när inkubatorer rankas
Uppsala innovation centre har rankats som världens fjärde bästa företagsinkubator med universitetskoppling.
-
Oasmia får ny ordförande
Karo Pharmas ordförande Anders Lönner föreslås även leda Oasmias styrelse i samband med en ny affär mellan bolagen.
-
Nytt bolag i hubben
Bioteknikbolaget Cereno Scientific är det senaste företaget som tar plats i Astrazenecas Bio Venture Hub.
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Ny teknik kan upptäcka alzheimer tidigare
Detektion av specifika former av proteinet tau i blodprover kan ge tidigare diagnostik av personer med alzheimer, redan innan de första symptomen uppstår.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Samuel Lagercrantz: Framgången kommer efter många misslyckanden
De allra flesta av de idéer och strategier mot covid-19 som man nu jobbar med kommer att gå i stöpet, men det kan räcka med att en enda fungerar, skriver Samuel Lagercrantz.
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Medicon Valley cluster in brief
The Medicon Valley covers the Öresund region (Skåne and Sjaelland).
BREAKING